Humana Inc. (HUM) raised its full-year earnings outlook on Wednesday after reporting better-than-expected results for the ...

Humana’s stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare ...

We recently published 10 Stocks With Shocking Surges. Humana Inc. (NYSE:HUM) is one of the best-performing stocks on ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...

Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a high estimate of $310.00 and a low estimate of $260.00. This current ...

Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue growth rate of 10.4% as of 31 December, 2024.

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.

It’s a significant loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.